Anchiano Therapeutics

Form 6-K

Anchiano Therapeutics Ltd. filed this Form 6-K on 05/28/2019

Document Outline:

PDF Form 6-K (LINK)

PDF Exhibit 99.1  (LINK) 

PDF Exhibit 99.2  (LINK) 

PDF Exhibit 99.3  (LINK) 

PDF Graphic  (LINK) 

PDF Graphic  (LINK) 

PDF Graphic  (LINK) 

PDF Complete Text Submission File  (LINK) 

 

 

Link to PR

NASDAQ: CMMB

 

Website Terms and Conditions of Use

View/Download 

Contact

Investor Relations:

Irina Koffler LifeSci Advisors, LLC

Email: ir@chemomab.com

Phone: +1-917-734-7387

 

Chemomab Therapeutics:

Sharon Elkobi VP, Business Development

Email: bd@chemomab.com

Phone: +972773310156

 

Anchiano Therapeutics © 2021